Research Austrlaia is now partnering with Genzyme. Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). We have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis. Visit their Facebook page and/or website for more information genzyme/
Posted on: Thu, 01 May 2014 02:31:11 +0000
Recently Viewed Topics
© 2015